Our understanding of anxiety and depression has evolved over the years, leading to advancements in diagnosis, treatment, and clinical management. However, their prevalence has not lessened; in fact, it has heightened in recent years due to the COVID-19 pandemic. Its effects will last for years to come, so all mechanisms that can influence its incidence
A new approach to antidepressants and anxiolytics: the microbiota-gut-brain axis originally appeared in KevinMD.com.
